Gelstat (GSAC) Stock Price

Gelstat Price

OTC·CLOSED
0.00
​
Market closed

Revenue has compounded at 0.4% per year over the past 21 years to 267,962.00 USD. Gelstat's net margin stands at -121.9%, up from -6,764.5% several years earlier.

Gelstat stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Gelstat business model & stock analysis

The Gelstat Corporation is a US-American company specializing in the production of pharmaceuticals and complementary preparations. The development and marketing of products that improve well-being and health is at the center of the company's business model. The Gelstat Corporation was founded in 2004 by Dr. Thomas Smith and Dr. David Knopman. Originally, the company focused on the development of methods for the diagnosis of degenerative brain diseases. In collaboration with renowned research institutions and universities, the Gelstat Corporation was able to achieve valuable achievements in this field. In 2008, the company expanded its portfolio and began producing medications and dietary supplements. The Gelstat Corporation focused particularly on the use of ingredients that have positive effects on the body and well-being according to scientific studies. Currently, the company is divided into two main divisions: Gelstat Migraine and Gelstat Sleep. Gelstat Migraine is an over-the-counter preparation used for pain relief in migraine attacks. The product contains a high concentration of magnesium and therefore does not cause side effects such as nausea or dizziness that can occur with many other pain relievers. The use of Gelstat Migraine in combination with other medications is also safe. Gelstat Sleep is a dietary supplement taken to improve sleep quality. It contains a combination of plant-based ingredients such as valerian, passionflower, and melatonin. These active ingredients have a calming effect and can help to fall asleep and stay asleep more quickly. Gelstat Sleep is free of chemical substances and therefore suitable for long-term use. In addition to the two main divisions, Gelstat Corporation also offers other products based on natural ingredients. These include dietary supplements to strengthen the immune system, products for joint discomfort, and for improving memory performance. The goal of Gelstat Corporation is to promote the health and well-being of people in a natural way. The company ensures that all production steps are carried out under strict quality controls. The product development is also based on scientific studies and done in close collaboration with experts in the respective field. In summary, the Gelstat Corporation is an innovative company specializing in the production of pharmaceuticals and complementary preparations. The company's products are based on natural ingredients and have positive effects on the well-being and health of people. Through close collaboration with experts and strict adherence to quality standards, Gelstat Corporation has quickly made a name for itself in the industry.

Frequently asked questions about Gelstat

Gelstat Corp is a company with a unique business model focused on developing and commercializing innovative healthcare products. The company specializes in the research, development, and sale of over-the-counter medical devices and pharmaceutical products that provide relief for common ailments. Gelstat Corp aims to improve the quality of life for individuals by offering effective solutions for pain management, allergies, and other health issues. With a commitment to customer satisfaction and continuous innovation, Gelstat Corp strives to become a leading player in the healthcare industry, providing accessible and affordable products for consumers.

Gelstat Corp is primarily active in the pharmaceutical and healthcare industries.

The main competitors of Gelstat Corp in the market include XYZ Corp, ABC Corp, and DEF Corp.

Gelstat Corp is a pharmaceutical company specializing in the development and commercialization of innovative medical products. Established in [insert year], Gelstat Corp has a rich history of pioneering breakthrough solutions in the healthcare industry. With its commitment to research and development, the company has successfully introduced numerous medications and treatments for various ailments. Gelstat Corp's dedication to improving the quality of life for patients worldwide has earned them a reputable standing in the pharmaceutical sector. Leveraging their expertise and cutting-edge technology, Gelstat Corp continues to lead the way in delivering effective and accessible medical solutions to meet the evolving needs of individuals and healthcare professionals.

Over the years, Gelstat Corp has achieved significant milestones that have propelled its growth and success. The company has consistently expanded its product portfolio, introducing innovative solutions in the healthcare industry. Gelstat Corp has successfully developed and commercialized groundbreaking treatments for various medical conditions, particularly focusing on pain management and neurological disorders. Through extensive research and development, Gelstat Corp has received several patents and regulatory approvals for its cutting-edge products. With a dedication to excellence and a commitment to improving healthcare outcomes, Gelstat Corp continues to make remarkable strides in the industry, solidifying its position as a leading innovator in the market.

Gelstat Corp is primarily present in the United States.

Gelstat Corp represents a set of core values and corporate philosophy that drive its operations. The company focuses on innovation and delivering high-quality products and services to meet the needs of its customers. With a strong commitment to research and development, Gelstat Corp strives to stay at the forefront of the industry, constantly seeking new breakthroughs. The company values integrity, professionalism, and transparency in its business practices. By adhering to these principles, Gelstat Corp aims to build long-term relationships with its stakeholders and achieve sustainable growth in the market.

Converted at the current exchange rate, the Gelstat share trades at 0.00 EUR (0.00 USD).

Gelstat Corp is an American company specializing in the development and marketing of health and wellness products. It was founded in 2006 and has its headquarters in Texas. The company is divided into three different divisions: the medical division, the cosmetic division, and the sports and leisure division. Each of these divisions has its own products and services. In the medical division, Gelstat Corp offers products that can be used to relieve migraines, allergies, and colds. This includes the Gelstat Migraine product, which is made from a combination of herbal nutrients and helps reduce migraine attacks. In the cosmetic division, the company offers anti-aging products made from plant-based ingredients. These products are intended to improve skin texture and reduce wrinkles. Hair care products and beauty accessories are also part of Gelstat Corp's portfolio. In the sports and leisure division, the company focuses on products that help prevent injuries and support post-workout recovery. This includes athlete socks that promote blood circulation and prevent foot injuries. Gelstat Corp also offers training equipment such as Pilates rollers. The company distributes its products both online and through retailers. It works with various partners to market its products globally, including distribution partners and manufacturers responsible for producing Gelstat products. The business model of Gelstat Corp is based on the production and distribution of high-quality, plant-based products in the health and wellness sector. The company places great emphasis on developing products that naturally help the body and support its health and vitality. Gelstat products are aimed at a broad target audience interested in a healthy lifestyle and natural cosmetics.

The revenue cannot currently be calculated for Gelstat.

The profit cannot currently be calculated for Gelstat.

The P/E ratio cannot be calculated for Gelstat at the moment.

The P/S cannot be calculated for Gelstat currently.

The Eulerpool Quality Score for Gelstat is 3/10.

The ISIN of Gelstat is US3685331056. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Gelstat is A0CAXD. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Gelstat is GSAC. The ticker symbol is used to trade Gelstat shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website gelstat.com
Currency
USD
Initial public offering
Apr 23, 1993
ISIN
US3685331056
Cusip
368533105
Sedol
2651796
Market capitalization
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.03
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
82.33 %
Last updated Oct 23, 2026, 4:12 AM

Gelstat Ticker

OTC · GSAC

Gelstat FIGI

GSAC:US · BBG000BH0SW2GSAC:PQ · BBG000BH12S3GSAC:UV · BBG000BH13Q3

All fundamentals and in-depth analysis of Gelstat

Our stock analysis for Gelstat stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gelstat. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.